Usanee Reinprayoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Usanee Reinprayoon has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Ngamjit Kasetsuwan
Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
9 shared publications - Vilavun Puangsricharern
Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
6 shared publications - Vannarut Satitpitakul
Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
4 shared publications Ngamjit Kasetsuwan
Center of Excellence for Cornea and Stem Cell Transplantation, Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
3 shared publications- Sunee Chansangpetch
Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
3 shared publications - Wasee Tulvatana
Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
3 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-13
Effect of Meibomian Gland Expression on Meibomian Gland Regeneration and Function: A Randomized Controlled Trial
Introduction: This study aims to compare the effect of meibomian gland expression (MGX) combined with lid hygiene versus lid hygiene alone on the meibomian gland’s morphology and function for obstructive meibomian gland dysfunction (oMGD). Methods: In this assessor-masked, parallel-group, randomized controlled trial, 64 oMGD patients with mild and moderate meibomian gland (MG) dropout were randomly allocated 1:1 into the MGX and control groups. All participants were informed to do lid hygiene once daily, while the intervention group received MGX every 2 weeks. The primary outcome was the change in MG dropout. Secondary outcomes included the Ocular Surface Disease Index (OSDI), tear stability, MG functions, changes in tear cytokine levels, and safety of MGX in a 12-week follow-up. Results: Sixty-two eyes of sixty-two patients were enrolled in this study. The dropout area of MG decreased significantly in both groups following treatment at all time points. The recovery was faster in the MGX group at 4 weeks (p< 0.001). However, no significant difference was observed between the groups after 8 to 12 weeks. Additionally, the MGX group also showed better improvement in OSDI and meibum quality than the control group, while no significant differences were observed between groups for other measures. No adverse events were reported, and the pain level was mild. Conclusion: MGX combined with lid hygiene results in a 13% reduction in MG dropout in the upper and lower eyelids. Moreover, the rate of improvement in MG morphology was faster in patients who underwent additional MGX than in those who performed lid hygiene alone.
- 1 June 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-13
Open AccessEffect of Meibomian Gland Expression on Meibomian Gland Regeneration and Function: A Randomized Controlled Trial
Introduction: This study aims to compare the effect of meibomian gland expression (MGX) combined with lid hygiene versus lid hygiene alone on the meibomian gland’s morphology and function for obstructive meibomian gland dysfunction (oMGD). Methods: In this assessor-masked, parallel-group, randomized controlled trial, 64 oMGD patients with mild and moderate meibomian gland (MG) dropout were randomly allocated 1:1 into the MGX and control groups. All participants were informed to do lid hygiene once daily, while the intervention group received MGX every 2 weeks. The primary outcome was the change in MG dropout. Secondary outcomes included the Ocular Surface Disease Index (OSDI), tear stability, MG functions, changes in tear cytokine levels, and safety of MGX in a 12-week follow-up. Results: Sixty-two eyes of sixty-two patients were enrolled in this study. The dropout area of MG decreased significantly in both groups following treatment at all time points. The recovery was faster in the MGX group at 4 weeks (p< 0.001). However, no significant difference was observed between the groups after 8 to 12 weeks. Additionally, the MGX group also showed better improvement in OSDI and meibum quality than the control group, while no significant differences were observed between groups for other measures. No adverse events were reported, and the pain level was mild. Conclusion: MGX combined with lid hygiene results in a 13% reduction in MG dropout in the upper and lower eyelids. Moreover, the rate of improvement in MG morphology was faster in patients who underwent additional MGX than in those who performed lid hygiene alone.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-14
Corneal Biomechanics Before and After Descemet Membrane Endothelial Keratoplasty in Patients with Fuchs Endothelial Corneal Dystrophy
Descemet Membrane Endothelial Keratoplasty (DMEK) is a surgical intervention for restoring endothelial function in Fuchs endothelial corneal dystrophy (FECD). However, changes in corneal biomechanical properties assessed using dynamic Scheimpflug analyzer (DSA) remain limited. This study aimed to assess alterations in corneal biomechanical parameters before and after surgery in patients with FECD using DSA. This prospective study included 24 FECD patients. Demographic data, visual acuity, central corneal thickness (CCT), endothelial cell count, intraocular pressure (IOP), stress strain index (SSI) and others DSA parameters were evaluated. Measurements were obtained preoperatively and at 1, 3, and 6 months after surgery. Repeated measures analysis of variance and pairwise correlations were used to assess differences and associations. Significant postoperative alterations were observed in multiple corneal biomechanical parameters. CCT, ARTh, A1 length, A1 DefA and SPA showed significant reductions over time. Conversely, the DefA max, maximum inverse radius, DA ratio, integrated radius and CBI significantly increased during follow-up. While, SSI remained stable at all time points. These findings demonstrate a biomechanical transformation following DMEK from 1 to 6 months postoperatively, reflecting the transition from a swollen, thickened cornea to a thinner, clearer cornea in the postoperative state. DMEK resulted in reduced corneal thickness and significant changes in several corneal biomechanical parameters. However, the stability of SSI, which is independent of CCT and bIOP, suggests that intrinsic corneal stiffness remains unchanged despite postoperative remodeling. The observed biomechanical alterations may provide useful markers for monitoring corneal recovery following DMEK.
- 1 May 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-14
Open AccessCorneal Biomechanics Before and After Descemet Membrane Endothelial Keratoplasty in Patients with Fuchs Endothelial Corneal Dystrophy
Descemet Membrane Endothelial Keratoplasty (DMEK) is a surgical intervention for restoring endothelial function in Fuchs endothelial corneal dystrophy (FECD). However, changes in corneal biomechanical properties assessed using dynamic Scheimpflug analyzer (DSA) remain limited. This study aimed to assess alterations in corneal biomechanical parameters before and after surgery in patients with FECD using DSA. This prospective study included 24 FECD patients. Demographic data, visual acuity, central corneal thickness (CCT), endothelial cell count, intraocular pressure (IOP), stress strain index (SSI) and others DSA parameters were evaluated. Measurements were obtained preoperatively and at 1, 3, and 6 months after surgery. Repeated measures analysis of variance and pairwise correlations were used to assess differences and associations. Significant postoperative alterations were observed in multiple corneal biomechanical parameters. CCT, ARTh, A1 length, A1 DefA and SPA showed significant reductions over time. Conversely, the DefA max, maximum inverse radius, DA ratio, integrated radius and CBI significantly increased during follow-up. While, SSI remained stable at all time points. These findings demonstrate a biomechanical transformation following DMEK from 1 to 6 months postoperatively, reflecting the transition from a swollen, thickened cornea to a thinner, clearer cornea in the postoperative state. DMEK resulted in reduced corneal thickness and significant changes in several corneal biomechanical parameters. However, the stability of SSI, which is independent of CCT and bIOP, suggests that intrinsic corneal stiffness remains unchanged despite postoperative remodeling. The observed biomechanical alterations may provide useful markers for monitoring corneal recovery following DMEK.
- Open Access
- 24 February 2026
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 16  (1)
Emerging zoonotic ocular sporotrichosis in southeast Asia: a case series from Thailand and systematic review of regional reports
Background: To describe the clinical features, diagnostic approaches, and treatment outcomes of ocular sporotrichosis through an institutional case series and systematic review of reports from Southeast Asia. Methods: Five patients diagnosed with ocular sporotrichosis at a tertiary referral center in Thailand (2020–2024) were retrospectively reviewed for clinical presentation, diagnostic confirmation, and treatment outcomes. A systematic review of PubMed, Embase, Scopus, and MEDLINE (last searched March 20, 2025) identified published cases from Southeast Asia. Eligible reports were narratively synthesized; no meta-analysis was performed due to clinical heterogeneity. Results: All five institutional cases presented with chronic granulomatous conjunctivitis, frequently associated with cat exposure. Diagnosis was confirmed by fungal culture and/or histopathology in all patients. Oral itraconazole was prescribed in every case, with adjunctive topical antifungals used selectively. Most patients improved clinically, though several were lost to follow-up. The systematic review included 12 studies comprising 23 patients reported between 2018 and 2024. The median age was 32 years (IQR 22.5–55.0), and 78.3% were female. Most cases were unilateral (91.3%), with microbiological confirmation in 87%. Oral itraconazole was the primary treatment, with topical or intralesional antifungals in some cases. Clinical outcomes were generally favorable, though one patient developed limbal stem cell deficiency. Conclusions: Ocular sporotrichosis is an emerging zoonotic infection in Southeast Asia, often linked to cat exposure. Early recognition and prompt antifungal therapy are critical to achieve good outcomes and prevent sight-threatening complications.
- 24 February 2026
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 16  (1)
Open AccessEmerging zoonotic ocular sporotrichosis in southeast Asia: a case series from Thailand and systematic review of regional reports
Background: To describe the clinical features, diagnostic approaches, and treatment outcomes of ocular sporotrichosis through an institutional case series and systematic review of reports from Southeast Asia. Methods: Five patients diagnosed with ocular sporotrichosis at a tertiary referral center in Thailand (2020–2024) were retrospectively reviewed for clinical presentation, diagnostic confirmation, and treatment outcomes. A systematic review of PubMed, Embase, Scopus, and MEDLINE (last searched March 20, 2025) identified published cases from Southeast Asia. Eligible reports were narratively synthesized; no meta-analysis was performed due to clinical heterogeneity. Results: All five institutional cases presented with chronic granulomatous conjunctivitis, frequently associated with cat exposure. Diagnosis was confirmed by fungal culture and/or histopathology in all patients. Oral itraconazole was prescribed in every case, with adjunctive topical antifungals used selectively. Most patients improved clinically, though several were lost to follow-up. The systematic review included 12 studies comprising 23 patients reported between 2018 and 2024. The median age was 32 years (IQR 22.5–55.0), and 78.3% were female. Most cases were unilateral (91.3%), with microbiological confirmation in 87%. Oral itraconazole was the primary treatment, with topical or intralesional antifungals in some cases. Clinical outcomes were generally favorable, though one patient developed limbal stem cell deficiency. Conclusions: Ocular sporotrichosis is an emerging zoonotic infection in Southeast Asia, often linked to cat exposure. Early recognition and prompt antifungal therapy are critical to achieve good outcomes and prevent sight-threatening complications.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 4585-4596
Post-Cataract Surgery Endophthalmitis Prophylaxis Survey in Thai Ophthalmologists
To determine current perioperative practice patterns for the prevention of endophthalmitis following cataract surgery in Thailand. Cross-sectional Survey Study. An online questionnaire was distributed nationwide to certified ophthalmologists, consisting of 21 questions covering 10 preoperative, 7 intraoperative, and 4 postoperative measures for the prevention of post-cataract surgery endophthalmitis. Subgroup analyses were performed to compare practices between general ophthalmologists, retina/uveitis specialists (R/U), and other subspecialists (Non-R/U). A total of 426 responses were analyzed. Preoperative topical antibiotics (21.1%, n = 90) and oral antibiotics (4.9%, n = 21) were rarely prescribed. The most common antiseptic for skin preparation was 10% povidone-iodine (72.3%, n = 308). Intracameral antibiotics were adopted by 54.7% of respondents (n = 233). Postoperative topical antibiotics were almost universally prescribed (99.5%, n = 424). Moxifloxacin was the most preferred topical (preoperative: 45.6%, n = 41, postoperative: 46.4%, n = 197) and intracameral (57.1%, n = 133) antibiotic. Subspecialty analysis revealed that R/U specialists were more prone to use 10% povidone-iodine (relative risk ratio [RRR] 2.37, 95% CI 1.16 to 4.82) and antiseptic applied to fornix (RRR 2.62, 95% CI 1.26 to 5.46) than the general ophthalmologist group. Although the majority of Thai ophthalmologists align their practices with international endophthalmitis prevention guidelines, certain practices were less frequently adopted than recommended. These findings emphasize the need for standardized national practice patterns to enhance surgical outcomes.
- 1 December 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 4585-4596
Open AccessPost-Cataract Surgery Endophthalmitis Prophylaxis Survey in Thai Ophthalmologists
To determine current perioperative practice patterns for the prevention of endophthalmitis following cataract surgery in Thailand. Cross-sectional Survey Study. An online questionnaire was distributed nationwide to certified ophthalmologists, consisting of 21 questions covering 10 preoperative, 7 intraoperative, and 4 postoperative measures for the prevention of post-cataract surgery endophthalmitis. Subgroup analyses were performed to compare practices between general ophthalmologists, retina/uveitis specialists (R/U), and other subspecialists (Non-R/U). A total of 426 responses were analyzed. Preoperative topical antibiotics (21.1%, n = 90) and oral antibiotics (4.9%, n = 21) were rarely prescribed. The most common antiseptic for skin preparation was 10% povidone-iodine (72.3%, n = 308). Intracameral antibiotics were adopted by 54.7% of respondents (n = 233). Postoperative topical antibiotics were almost universally prescribed (99.5%, n = 424). Moxifloxacin was the most preferred topical (preoperative: 45.6%, n = 41, postoperative: 46.4%, n = 197) and intracameral (57.1%, n = 133) antibiotic. Subspecialty analysis revealed that R/U specialists were more prone to use 10% povidone-iodine (relative risk ratio [RRR] 2.37, 95% CI 1.16 to 4.82) and antiseptic applied to fornix (RRR 2.62, 95% CI 1.26 to 5.46) than the general ophthalmologist group. Although the majority of Thai ophthalmologists align their practices with international endophthalmitis prevention guidelines, certain practices were less frequently adopted than recommended. These findings emphasize the need for standardized national practice patterns to enhance surgical outcomes.
- Open Access
- 1 October 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 3949-3960
Systematic Review of Clinical Practice Guidelines for Post-Cataract Surgery Endophthalmitis Prophylaxis from 2008-2023
Postoperative endophthalmitis remains a significant concern following cataract surgery with a potential for severe vision loss. Although numerous clinical practice guidelines (CPGs) have been published worldwide, they offer differing recommendations for prophylactic measures. This systematic review aimed to synthesize and evaluate existing guidelines for endophthalmitis prophylaxis after cataract surgery. A comprehensive search including citation and gray literature search was conducted. Authors’ contact with peer international ophthalmologists was also employed. Clinical practice guidelines specifically on post-cataract surgery endophthalmitis prophylaxis published between 2008 and 2023 were included in this study. Quality assessment was done using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool. Twenty-one guidelines were identified, assessed, and extracted. Intracameral antibiotics, instillation of povidone-iodine into the conjunctival sac, and periorbital skin preparation with povidone-iodine were the most commonly endorsed measures, although recommended concentrations, dosages, and contact times varied. Several guidelines did not address ancillary measures, such as face washing, postoperative eye protection or adjunctive topical antibiotics. While core prophylactic strategies were broadly agreed upon, significant differences persisted likely due to disparate local regulations, idiosyncratic practices, and interpretations of the evidence. Careful selection and employment of any procedure should be tailored according to patient characteristics and circumstances.
- 1 October 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 3949-3960
Open AccessSystematic Review of Clinical Practice Guidelines for Post-Cataract Surgery Endophthalmitis Prophylaxis from 2008-2023
Postoperative endophthalmitis remains a significant concern following cataract surgery with a potential for severe vision loss. Although numerous clinical practice guidelines (CPGs) have been published worldwide, they offer differing recommendations for prophylactic measures. This systematic review aimed to synthesize and evaluate existing guidelines for endophthalmitis prophylaxis after cataract surgery. A comprehensive search including citation and gray literature search was conducted. Authors’ contact with peer international ophthalmologists was also employed. Clinical practice guidelines specifically on post-cataract surgery endophthalmitis prophylaxis published between 2008 and 2023 were included in this study. Quality assessment was done using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool. Twenty-one guidelines were identified, assessed, and extracted. Intracameral antibiotics, instillation of povidone-iodine into the conjunctival sac, and periorbital skin preparation with povidone-iodine were the most commonly endorsed measures, although recommended concentrations, dosages, and contact times varied. Several guidelines did not address ancillary measures, such as face washing, postoperative eye protection or adjunctive topical antibiotics. While core prophylactic strategies were broadly agreed upon, significant differences persisted likely due to disparate local regulations, idiosyncratic practices, and interpretations of the evidence. Careful selection and employment of any procedure should be tailored according to patient characteristics and circumstances.
- Open Access
- 27 June 2025
- Published by Springer Nature in Eye
- Vol. 39  (12) , 2451-2459
Randomized, double-masked, sham-controlled trial of efficacy and safety of quantum molecular resonance for treating meibomian gland dysfunction
Background: This randomized, double-blind, sham-controlled trial aimed to evaluate the novel quantum molecular resonance (QMR) device for meibomian gland dysfunction (MGD) treatment. Methods: Eighty participants diagnosed with MGD were randomized into QMR or sham-QMR groups. Each procedure was performed on days 0, 7, 14, and 21. Primary (meibum quality score) and other secondary outcomes were examined at baseline and weeks 7 and 11. Tear osmolarity and interleukin (IL)-6 and IL-1 receptor agonist levels were evaluated at baseline and week 7. Adverse events were recorded. A multilevel mixed-effect linear regression model was used for data analysis. Results: Meibum quality (p = 0.008), corneal/conjunctival fluorescein staining score (p = 0.036), telangiectatic vessel area (p = 0.008), and superior (p = 0.011) and inferior (p = 0.020) lid meiboscale were significantly improved in the QMR group than those in the sham-treated group at week 11. Superior lid meiboscale (p = 0.027) and meibomian gland plugging grade (MGPG) (p = 0.017) were significantly improved in the QMR group at week 7. In the QMR group, Ocular Surface Disease Index (OSDI) scores and lid margin thickening grades were significantly lesser at weeks 7 (p = 0.002 and p < 0.001) than the baseline values. At week 7, IL-6 levels were significantly decreased only in the QMR group (p = 0.016). All other parameters did not significantly differ. No serious adverse event occurred. Conclusions: The QMR device was effective for MGD treatment, with improvements in meibum quality, corneal/conjunctival staining, telangiectatic vessels, MGPG, superior and inferior lid meiboscale, and decreased OSDI score, lid margin thickening grade, and tear IL-6 level.
- 27 June 2025
- Published by Springer Nature in Eye
- Vol. 39  (12) , 2451-2459
Open AccessRandomized, double-masked, sham-controlled trial of efficacy and safety of quantum molecular resonance for treating meibomian gland dysfunction
Background: This randomized, double-blind, sham-controlled trial aimed to evaluate the novel quantum molecular resonance (QMR) device for meibomian gland dysfunction (MGD) treatment. Methods: Eighty participants diagnosed with MGD were randomized into QMR or sham-QMR groups. Each procedure was performed on days 0, 7, 14, and 21. Primary (meibum quality score) and other secondary outcomes were examined at baseline and weeks 7 and 11. Tear osmolarity and interleukin (IL)-6 and IL-1 receptor agonist levels were evaluated at baseline and week 7. Adverse events were recorded. A multilevel mixed-effect linear regression model was used for data analysis. Results: Meibum quality (p = 0.008), corneal/conjunctival fluorescein staining score (p = 0.036), telangiectatic vessel area (p = 0.008), and superior (p = 0.011) and inferior (p = 0.020) lid meiboscale were significantly improved in the QMR group than those in the sham-treated group at week 11. Superior lid meiboscale (p = 0.027) and meibomian gland plugging grade (MGPG) (p = 0.017) were significantly improved in the QMR group at week 7. In the QMR group, Ocular Surface Disease Index (OSDI) scores and lid margin thickening grades were significantly lesser at weeks 7 (p = 0.002 and p < 0.001) than the baseline values. At week 7, IL-6 levels were significantly decreased only in the QMR group (p = 0.016). All other parameters did not significantly differ. No serious adverse event occurred. Conclusions: The QMR device was effective for MGD treatment, with improvements in meibum quality, corneal/conjunctival staining, telangiectatic vessels, MGPG, superior and inferior lid meiboscale, and decreased OSDI score, lid margin thickening grade, and tear IL-6 level.
- Open Access
- 16 September 2024
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 9  (1) , e001581
Microsporidial stromal keratitis: treatment outcomes, clinical manifestations, confocal microscopy and histopathology findings: a retrospective observational study
Objective: Microsporidial stromal keratitis (MSK) is an uncommon disease. Only several case series have been reported. We aimed to describe the clinical manifestations, histopathology and treatment outcomes of MSK. Methods and analysis: Retrospective data of MSK diagnosed between January 2009 and December 2020 at the King Chulalongkorn Memorial Hospital, Bangkok, Thailand were retrieved. The diagnosis was made based on corneal scraping, corneal biopsy and corneal button histopathology findings. Detailed clinical characteristics, histopathological findings and treatment outcomes were reviewed and analysed. Results: 21 patients with MSK with a mean age of 63.8 years (SD 12.2) had an indolent disease onset with a median of 9 months (IQR 2.2–12.0). Five patients (23.8%) experienced ocular traumas. Herpes stromal keratitis was the most common preliminary diagnosis (33.3%), followed by non-specific ulcers and fungal keratitis. The most common corneal finding was multifocal grey-white lesions with anterior to mid-stromal infiltration and fluffy borders (66.7%). Pathogens were identified by modified trichrome staining of corneal scrapings in 11 of 14 cases (78.6%). Histopathological examination showed positive Ziehl-Neelsen staining in 17 of 19 cases (89.5%). All patients received surgical treatment, with 18 receiving therapeutic penetrating keratoplasty (TPK), 2 undergoing deep anterior lamellar keratoplasty and 1 undergoing femtosecond laser-assisted anterior lamellar keratoplasty. The overall cure rate was 76.2% after the first surgery and 95.2% after the second surgery. Conclusion: MSK can be easily underdiagnosed. Clues to diagnosis included a history of chronic refractory stromal infiltration and typical corneal findings of deep stromal infiltration, without epithelial defects. TPK is the preferred treatment for MSK.
- 16 September 2024
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 9  (1) , e001581
Open AccessMicrosporidial stromal keratitis: treatment outcomes, clinical manifestations, confocal microscopy and histopathology findings: a retrospective observational study
Objective: Microsporidial stromal keratitis (MSK) is an uncommon disease. Only several case series have been reported. We aimed to describe the clinical manifestations, histopathology and treatment outcomes of MSK. Methods and analysis: Retrospective data of MSK diagnosed between January 2009 and December 2020 at the King Chulalongkorn Memorial Hospital, Bangkok, Thailand were retrieved. The diagnosis was made based on corneal scraping, corneal biopsy and corneal button histopathology findings. Detailed clinical characteristics, histopathological findings and treatment outcomes were reviewed and analysed. Results: 21 patients with MSK with a mean age of 63.8 years (SD 12.2) had an indolent disease onset with a median of 9 months (IQR 2.2–12.0). Five patients (23.8%) experienced ocular traumas. Herpes stromal keratitis was the most common preliminary diagnosis (33.3%), followed by non-specific ulcers and fungal keratitis. The most common corneal finding was multifocal grey-white lesions with anterior to mid-stromal infiltration and fluffy borders (66.7%). Pathogens were identified by modified trichrome staining of corneal scrapings in 11 of 14 cases (78.6%). Histopathological examination showed positive Ziehl-Neelsen staining in 17 of 19 cases (89.5%). All patients received surgical treatment, with 18 receiving therapeutic penetrating keratoplasty (TPK), 2 undergoing deep anterior lamellar keratoplasty and 1 undergoing femtosecond laser-assisted anterior lamellar keratoplasty. The overall cure rate was 76.2% after the first surgery and 95.2% after the second surgery. Conclusion: MSK can be easily underdiagnosed. Clues to diagnosis included a history of chronic refractory stromal infiltration and typical corneal findings of deep stromal infiltration, without epithelial defects. TPK is the preferred treatment for MSK.
- Open Access
- 1 December 2022
- Vol. 16  (6) , 316-321
Keratoconus in Thai population - a cross-sectional hospital-based study
Background: Studies in the epidemiology of keratoconus are limited in Southeast Asia. A study on the prevalence and characteristics of keratoconus in the Thai population could give a general idea of its impact. Objectives: To study keratoconus prevalence in patients seeking refractive surgery and analyze the characteristics of keratoconus. Methods: Medical records from April 2015 to August 2018 were retrospectively reviewed. Keratoconus and keratoconus suspect prevalence in patients seeking laser vision correction were calculated. The characteristics of keratoconus patients were reviewed. The Amsler-Krumeich classification was used to determine the stages. Topographically, the types of cones were categorized into oval, nipple, pellucid marginal degeneration (PMD)-like, and astigmatic types. Results: Keratoconus and keratoconus suspect prevalence were 1.66% and 0.68%, respectively. Out of the affected patients, 73.8% were male. The mean age at diagnosis was 25.25 +/- 8.35 years. The presenting symptoms were blurred vision (87%) and itching (47%). Stage 1 was predominant, found in 39% of patients (followed by stages 2, 4, and 3, respectively). Ocular findings comprised the Munson sign (14.63%), the Rizutti sign (6.94%), Fleischer ring (28.14%), Vogt striae (24.95%), corneal scar (8.63%), prominent corneal nerve (2.81%), and corneal staining (7.69%). Mean uncorrected visual acuity (logarithm of the minimum angle of resolution [logMAR]) was 0.88 +/- 0.64. Mean corrected visual acuity (logMAR) was 0.40 +/- 0.49. Mean Q-value was -0.92 +/- 0.63. The thinnest pachymetry was 459.39 +/- 56.96 microns. The mean keratometry was 49.7 +/- 6.64 diopters. Topographically, the types of cones were oval (57%), astigmatic (33%), PMD-like (5%), and nipple type (4%). Conclusions: Keratoconus prevalence among Thai patients seeking refractive surgery was 1.66%. Most patients were male and presented with the disease at a mild bilateral stage in their second decade of life.
- 1 December 2022
- Vol. 16  (6) , 316-321
Open AccessKeratoconus in Thai population - a cross-sectional hospital-based study
Background: Studies in the epidemiology of keratoconus are limited in Southeast Asia. A study on the prevalence and characteristics of keratoconus in the Thai population could give a general idea of its impact. Objectives: To study keratoconus prevalence in patients seeking refractive surgery and analyze the characteristics of keratoconus. Methods: Medical records from April 2015 to August 2018 were retrospectively reviewed. Keratoconus and keratoconus suspect prevalence in patients seeking laser vision correction were calculated. The characteristics of keratoconus patients were reviewed. The Amsler-Krumeich classification was used to determine the stages. Topographically, the types of cones were categorized into oval, nipple, pellucid marginal degeneration (PMD)-like, and astigmatic types. Results: Keratoconus and keratoconus suspect prevalence were 1.66% and 0.68%, respectively. Out of the affected patients, 73.8% were male. The mean age at diagnosis was 25.25 +/- 8.35 years. The presenting symptoms were blurred vision (87%) and itching (47%). Stage 1 was predominant, found in 39% of patients (followed by stages 2, 4, and 3, respectively). Ocular findings comprised the Munson sign (14.63%), the Rizutti sign (6.94%), Fleischer ring (28.14%), Vogt striae (24.95%), corneal scar (8.63%), prominent corneal nerve (2.81%), and corneal staining (7.69%). Mean uncorrected visual acuity (logarithm of the minimum angle of resolution [logMAR]) was 0.88 +/- 0.64. Mean corrected visual acuity (logMAR) was 0.40 +/- 0.49. Mean Q-value was -0.92 +/- 0.63. The thinnest pachymetry was 459.39 +/- 56.96 microns. The mean keratometry was 49.7 +/- 6.64 diopters. Topographically, the types of cones were oval (57%), astigmatic (33%), PMD-like (5%), and nipple type (4%). Conclusions: Keratoconus prevalence among Thai patients seeking refractive surgery was 1.66%. Most patients were male and presented with the disease at a mild bilateral stage in their second decade of life.
- Open Access
- 20 August 2022
- Published by Springer Nature in Eye
- Vol. 37  (2) , 373-374
Longitudinal evaluation of corneal tomography after small incision lenticule extraction
- 20 August 2022
- Published by Springer Nature in Eye
- Vol. 37  (2) , 373-374
Open AccessLongitudinal evaluation of corneal tomography after small incision lenticule extraction
- Open Access
- 22 June 2022
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 10  (6) , e31011
Assessing the Risk Factors For Diagnosed Symptomatic Dry Eye Using a Smartphone App: Cross-sectional Study
Background: Dry eye (DE) is a chronic inflammatory disease of the ocular surface of the eye that affects millions of people throughout the world. Smartphone use as an effective health care tool has grown exponentially. The “Dry eye or not?” app was created to evaluate the prevalence of symptomatic DE, screen for its occurrence, and provide feedback to users with symptomatic DE throughout Thailand. Objective: The purpose of this study was to compare the prevalence of symptomatic dry eye (DE), blink rate, maximum blink interval (MBI), and best spectacle-corrected visual acuity (BSCVA) between people with and without symptomatic DE and to identify risk factors for symptomatic DE in Thailand. Methods: This cross-sectional study sourced data from the “Dry eye or not?” smartphone app between November 2019 and July 2020. This app collected demographic data, Ocular Surface Disease Index (OSDI) score, blink rate, MBI, BSCVA, and visual display terminal (VDT) use data. The criterion for symptomatic DE was OSDI score ≥13. Results: The prevalence of symptomatic DE among individuals using this smartphone app in Thailand was 85.8% (8131/9482), with the Northeastern region of Thailand having the highest prevalence, followed by the Northern region. Worse BSCVA (median 0.20, IQR 0.40; P=.02), increased blink rate (median 18, IQR 16; P<.001), reduced MBI (median 8.90, IQR 10.80; P<.001), female sex (adjusted OR 1.83; 95% CI 1.59-2.09; P<.001), more than 6 hours of VDT use (adjusted OR 1.59; 95% CI 1.15-2.19; P=.004), and lower than bachelor’s degree (adjusted OR 1.30; 95% CI 1.03-1.64; P=.02) were significantly associated with symptomatic DE. An age over 50 years (adjusted OR 0.77; 95% CI 0.60-0.99) was significantly less associated with symptomatic DE (P=.04). Conclusions: This smartphone DE app showed that the prevalence of symptomatic DE in Thailand was 85.8%. Signs and risk factors could be also evaluated with this smartphone DE app. Screening for DE by this app may allow for the development of strategic plans for health care systems in Thailand.
- 22 June 2022
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 10  (6) , e31011
Open AccessAssessing the Risk Factors For Diagnosed Symptomatic Dry Eye Using a Smartphone App: Cross-sectional Study
Background: Dry eye (DE) is a chronic inflammatory disease of the ocular surface of the eye that affects millions of people throughout the world. Smartphone use as an effective health care tool has grown exponentially. The “Dry eye or not?” app was created to evaluate the prevalence of symptomatic DE, screen for its occurrence, and provide feedback to users with symptomatic DE throughout Thailand. Objective: The purpose of this study was to compare the prevalence of symptomatic dry eye (DE), blink rate, maximum blink interval (MBI), and best spectacle-corrected visual acuity (BSCVA) between people with and without symptomatic DE and to identify risk factors for symptomatic DE in Thailand. Methods: This cross-sectional study sourced data from the “Dry eye or not?” smartphone app between November 2019 and July 2020. This app collected demographic data, Ocular Surface Disease Index (OSDI) score, blink rate, MBI, BSCVA, and visual display terminal (VDT) use data. The criterion for symptomatic DE was OSDI score ≥13. Results: The prevalence of symptomatic DE among individuals using this smartphone app in Thailand was 85.8% (8131/9482), with the Northeastern region of Thailand having the highest prevalence, followed by the Northern region. Worse BSCVA (median 0.20, IQR 0.40; P=.02), increased blink rate (median 18, IQR 16; P<.001), reduced MBI (median 8.90, IQR 10.80; P<.001), female sex (adjusted OR 1.83; 95% CI 1.59-2.09; P<.001), more than 6 hours of VDT use (adjusted OR 1.59; 95% CI 1.15-2.19; P=.004), and lower than bachelor’s degree (adjusted OR 1.30; 95% CI 1.03-1.64; P=.02) were significantly associated with symptomatic DE. An age over 50 years (adjusted OR 0.77; 95% CI 0.60-0.99) was significantly less associated with symptomatic DE (P=.04). Conclusions: This smartphone DE app showed that the prevalence of symptomatic DE in Thailand was 85.8%. Signs and risk factors could be also evaluated with this smartphone DE app. Screening for DE by this app may allow for the development of strategic plans for health care systems in Thailand.